tirzepatide showed more weight loss in the treatment group than in the placebo group at three different doses: In a study looking at semaglutide, those who took a weekly dose of 2.4 mg for weight ...

A new analysis of FDA adverse event reports suggests a potential link between tirzepatide and thyroid cancer. Learn what this ...

Prices would require additional discounts of 30.5 and 81.9 percent for tirzepatide and semaglutide, respectively, from the current net prices in order to reach the $100,000/QALY threshold.

Mounjaro, an injectable medication designed to support weight loss, works by imitating the effects of two natural hormones, ...

Obesity is a chronic disorder characterized by excessive body weight (body mass index [BMI] ≥ 30 ... Tirzepatide utilization analyses revealed that 88.6% of patients were initiated on 2.5 mg ...

The cost of this drug ranges from ₹3,500 for a 2.5 mg vial to ₹4,375 for a 5 mg vial ... and ultimately lose weight.

Current Status of GLP-1 Medications The FDA has officially determined that the shortage of both semaglutide and tirzepatide injection products is now resolved. Semaglutide: The FDA determined on ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

In the study, patients first received a four-week treatment with tirzepatide alone (2.5 mg weekly) to confirm eligibility. They were then randomly assigned to one of four treatment groups for an ...